Search research articles
Contact Us
Filters
Showing results (61-70 of 1,015) with videos related to
Page
of 102
Sort By:
Pharmacological Reviews
|
March 2, 2006
Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol
Pál Pacher, Alex Nivorozhkin, Csaba Szabó
Lancet (London, England)
|
October 15, 2015
EXAMINE: targeting risk and treatment in diabetes
Martin Hülsmann, Richard Pacher, Stephanie Neuhold
Handbook of Experimental Pharmacology
|
April 7, 2006
Cardiovascular pharmacology of cannabinoids
P Pacher, S Bátkai, G Kunos
Methods in Molecular Biology (Clifton, N.J.)
|
November 12, 2018
DNA Break Repair in Plants and Its Application for Genome Engineering
Carla Schmidt, Michael Pacher, Holger Puchta
Medical Hypotheses
|
February 28, 2002
Can simvastatin promote tumor growth by inducing angiogenesis similar to VEGF?
Z Ungvari, P Pacher, A Csiszar
The Plant Journal : for Cell and Molecular Biology
|
March 23, 2019
Efficient induction of heritable inversions in plant genomes using the CRISPR/Cas system
Carla Schmidt, Michael Pacher, Holger Puchta
Vox Sanguinis
|
December 1, 1973
A further observation of a recombination within the HL-A system in an Austrian family
P Speiser, V Pausch, M Pacher
Neuropharmacology
|
May 25, 2005
Blood pressure regulation by endocannabinoids and their receptors
Pál Pacher, Sándor Bátkai, George Kunos
British Journal of Pharmacology
|
July 19, 2005
Cirrhotic cardiomyopathy: an endocannabinoid connection?
Pál Pacher, Sándor Bátkai, George Kunos
Diabetes Care
|
May 24, 2014
Comment on Hillis et al. The relative and combined ability of high-sensitivity cardiac troponin T and N-terminal pro-B-type natriuretic Peptide to predict cardiovascular events and death in patients with type 2 diabetes. Diabetes care 2014;37:295-303
Stephanie Neuhold, Richard Pacher, Martin Hülsmann
Page
of 102
Search research articles
Search
Showing results (61-70 of 1,015) with videos related to
Sort By:
Page
of 102
Pharmacological Reviews
|
March 2, 2006
Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol
Pál Pacher, Alex Nivorozhkin, Csaba Szabó
Lancet (London, England)
|
October 15, 2015
EXAMINE: targeting risk and treatment in diabetes
Martin Hülsmann, Richard Pacher, Stephanie Neuhold
Handbook of Experimental Pharmacology
|
April 7, 2006
Cardiovascular pharmacology of cannabinoids
P Pacher, S Bátkai, G Kunos
Methods in Molecular Biology (Clifton, N.J.)
|
November 12, 2018
DNA Break Repair in Plants and Its Application for Genome Engineering
Carla Schmidt, Michael Pacher, Holger Puchta
Medical Hypotheses
|
February 28, 2002
Can simvastatin promote tumor growth by inducing angiogenesis similar to VEGF?
Z Ungvari, P Pacher, A Csiszar
The Plant Journal : for Cell and Molecular Biology
|
March 23, 2019
Efficient induction of heritable inversions in plant genomes using the CRISPR/Cas system
Carla Schmidt, Michael Pacher, Holger Puchta
Vox Sanguinis
|
December 1, 1973
A further observation of a recombination within the HL-A system in an Austrian family
P Speiser, V Pausch, M Pacher
Neuropharmacology
|
May 25, 2005
Blood pressure regulation by endocannabinoids and their receptors
Pál Pacher, Sándor Bátkai, George Kunos
British Journal of Pharmacology
|
July 19, 2005
Cirrhotic cardiomyopathy: an endocannabinoid connection?
Pál Pacher, Sándor Bátkai, George Kunos
Diabetes Care
|
May 24, 2014
Comment on Hillis et al. The relative and combined ability of high-sensitivity cardiac troponin T and N-terminal pro-B-type natriuretic Peptide to predict cardiovascular events and death in patients with type 2 diabetes. Diabetes care 2014;37:295-303
Stephanie Neuhold, Richard Pacher, Martin Hülsmann
Page
of 102